Use of a photon-counting-detector CT for renal stones is similar to using dual-energy CT.
Photon-counting–detector (PCD) CT is superior to standard CT in helping characterize small renal stones, according to a study published in the journal Radiology.
Researchers from the United States and Germany sought to evaluate the utility and efficacy of a PCD CT system in improving the automatic characterization of stones of 3 mm or smaller.
Ten women and 20 men, median age 61 years, participated in the study. All underwent a clinical renal stone characterization scan with dual-energy CT, followed by a research PCD CT scan with the same radiation dose. Two radiologists reviewed for stones, which were identified as uric acid or non–uric acid. Stone size and contrast-to-noise ratio were calculated.
The results showed 160 renal stones; 91 were 3 mm or smaller in axial length. The odds of detecting a stone at PCD CT were 1.29 for all stones, compared with 1-mm-thick routine images from dual-energy CT.
Stone segmentation and characterization were successful at PCD CT in 70.0% (112 of 160) of stones versus 54.4% (87 of 160) at dual-energy CT, and was superior for stones 3 mm or smaller at PCD CT (45 versus 25 stones, respectively). Stone characterization agreement between scanners for stones of all sizes was substantial.
The researchers concluded that using a PCD CT to detect renal stones was similar to using dual-energy CT, however the PCD CT was better able to help characterize small renal stones.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.